Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04167254 · ClinicalTrials.gov registry record · Phase 1

Sit Down and Play India

A Phase 1 study of Development, Child, sponsored by University of Illinois at Chicago.

Completed
Registry status
Phase 1
Development phase
59
Enrollment target
2
Study locations

NCT04167254 is a Phase 1 study of Development, Child that has completed, run by University of Illinois at Chicago. The registered enrollment target is 59 participants, below the 192-participant average among 5 other Development, Child trials with a reported enrollment target (69% lower). The trial reports 2 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04167254, a Phase 1 study of Development, Child, has completed, sponsored by University of Illinois at Chicago.

COMPLETED
Registry status
Phase 1
Development phase
59 participants
Enrollment target
2
Study locations

Study Summary

To gather data essential to evaluate the acceptability and feasibility of a brief, health care-based program delivered in routine healthcare visits in low and low-middle income countries to promote positive parenting behaviors with the aim to support early child development.

Conditions Studied

Interventions

  • BEHAVIORAL Sit Down and Play

Study Locations (2)

Illinois

  • University of Illinois at Chicago - Chicago

Karnataka

  • Deshnur Primary Health Center - Deshnur

Trial Details

FieldValue
Enrollment Target 59 participants
Start Date 2020-02-07
Est. Completion 2021-04-01
Phase Phase 1

Sponsor

University of Illinois at Chicago

430 total trials

What the Registry Record Tells You About NCT04167254

The ClinicalTrials.gov registry entry for NCT04167254 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 59 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 192-participant average among 5 other Development, Child trials with a reported enrollment target (69% lower). The listed sponsor is University of Illinois at Chicago, which has 430 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Development, Child appearing as the primary indexed condition, and to 1 intervention - of which Sit Down and Play is the first listed.

NCT04167254 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Illinois, Karnataka.

Frequently Asked Questions

What is clinical trial NCT04167254 about?

NCT04167254 is a clinical study titled "Sit Down and Play India". To gather data essential to evaluate the acceptability and feasibility of a brief, health care-based program delivered in routine healthcare visits in low and low-middle income countries to promote positive parenting behaviors with the aim to support early child development.

What is the current status of trial NCT04167254?

This trial is currently completed. It is a Phase 1 study. The enrollment target is 59 participants. The study started on 2020-02-07. Estimated completion is 2021-04-01.

What conditions does trial NCT04167254 study?

This clinical trial studies the following conditions: Development, Child.

What interventions are being tested in trial NCT04167254?

The interventions under investigation include: Sit Down and Play (BEHAVIORAL).

Who is sponsoring clinical trial NCT04167254?

This trial is sponsored by University of Illinois at Chicago, which has 430 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04167254 being conducted?

This trial has 2 study locations across Illinois, Karnataka. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Development, Child

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.